Neutrophil collagenase (matrix metalloproteinase-8 or MMP-8) is regarded as being synthesized exclusively by polymorphonuclear neutrophils (PMN). However, in vivo MMP-8 expression was observed in mononuclear fibroblast-like cells in the rheumatoid synovial membrane. In addition, we detected MMP-8 mRNA expression in cultured rheumatoid synovial fibroblasts and human endothelial cells. Up-regulation of MMP-8 was observed after treatment of the cells with either tumor necrosis factor-␣ (10 ng/ml) or phorbol 12-myristate 13-acetate (10 nM). Western analysis showed a similar regulation at the protein level. The size of secreted MMP-8 was 50 kDa, which is about 30 kDa smaller than MMP-8 from PMN. Conditioned media from rheumatoid synovial fibroblasts contained both type I and II collagen degrading activity. However, degradation of type II collagen, but not that of type I collagen, was completely inhibited by 50 M doxycycline, suggesting specific MMP-8 activity. In addition, doxycycline down-regulated MMP-8 induction, at both the mRNA and protein levels. Thus MMP-8 exerts markedly wider expression in human cells than had been thought previously, implying that PMN are not the only source of cartilage degrading activity at arthritic sites. The inhibition of both MMP-8 activity and synthesis by doxycycline provides an incentive for further studies on the clinical effects of doxycycline in the treatment of rheumatoid arthritis.
Extracellular matrix degradation is fundamental to connective tissue remodeling during physiological processes as well as during the progress of several pathological phenomena. Matrix turnover is regulated by a delicate balance among the production, activation, and inhibition of proteolytic enzymes. The matrix metalloproteinases (MMPs) 1 form a gene family of at least 14 enzymes participating in extracellular matrix remodeling. MMPs, together with the factors associated with their regulation, are reported to be highly implicated in various diseases such as rheumatoid arthritis, osteoarthritis, corneal ulceration, atherosclerosis, and tumor invasion and metastasis (for reviews, see Refs. [1] [2] [3] . Previous studies have demonstrated that neutrophil-derived MMPs such as collagenase (MMP-8) and gelatinase B (MMP-9, 92-kDa type IV collagenase), play a key role in the degradation of extracellular matrix constituents i.e. during the course of inflammatory diseases (4 -7). Collagenases exist as three distinct molecules, namely the fibroblast type (MMP-1, collagenase-1) (8), the neutrophil type (MMP-8) (9) , and collagenase-3 (MMP-13) (10) . They all are able to degrade specifically the fibrillar collagen types I, II, and III as well as type VII and X collagens (11, 12) , serpins (4, 13) , ␤-casein, and human ␣ 2 -macroglobulin (14) . Among collagenases, MMP-8 most effectively hydrolyzes the native type I and II collagens, whereas MMP-1 prefers type III collagen. MMP-8 is a considerably more efficient enzyme than MMP-1 with respect to almost all substrates except for type III collagen (9) . MMP-1 is transcribed and expressed by human fibroblasts, keratinocytes, endothelial cells, monocytes, and macrophages, and collagenase-3 by some human malignant breast tumors (10) , whereas MMP-8 has been shown to be stored in subcellular specific granules of mature human peripheral blood PMN after synthesis during PMN maturation in bone marrow (15) . Previous studies indicate that PMN MMP-8 transcription is completed before PMN emigrate from bone marrow (15) and that MMP-8 activity is regulated by factors that affect the release of MMP-8 by degranulation and not its biosynthesis (4) . However, by using in situ hybridization, Cole and Kuettner (16) have shown that MMP-8 mRNA is also found in peripheral PMN. More recent observations (17, 18) showed MMP-8 mRNA expression in human cartilage, primarily in chondrocytes. In this study we investigated the expression and regulation of MMP-8, particularly in human rheumatoid synovial fibroblasts (RSF) and endothelial cells. It was shown that MMP-8 is also expressed in cell types other than those belonging to the PMN lineage. In these cells MMP-8 is secreted as a nonglycosylated protein. The expression of MMP-8 in RSF and endothelial cells was up-regulated by tumor necrosis factor-␣ (TNF-␣) and phorbol 12-myristate 13-acetate (PMA). Doxycycline inhibited not only the catalytic activity of MMP-8, but also the expression of MMP-8 mRNA and protein.
EXPERIMENTAL PROCEDURES
Reagents-Medium 199 supplemented with 20 mM Hepes was purchased from Flow Laboratories (Irvine, Scotland, U. K.). Ham's nutrient mixture F-12 was from Northumbria Biologicals Ltd. (Cramlington, Northumberland, U. K.). Dulbecco's modified Eagle's medium, keratinocyte-SFM, as well as other cell culture reagents were obtained from Life Technologies, Inc. 4-Aminophenylmercuric acetate (APMA), CHAPS, PMA, endoglycosidase F, N-glycosidase F, polyoxyethylene 23 lauryl ether (Brij-35), and doxycycline were purchased from Sigma. Native type I and II collagen were isolated from bovine skin and articular cartilage and analyzed for purity by cyanogen bromide cleavage peptide analysis (5) . Human recombinant TNF-␣ (specific activity 2.45 ϫ 10 7 units/mg) was a gift from J. Tavenier (Biogent, Gent, Belgium). Hydrocortisone was from Diosynth, (Oss, The Netherlands). The avidin-biotin-horseradish peroxidase kit and peroxidase-anti-peroxidase (rabbit) were from Dako A/S (DK-2600 Glostrup, Denmark).
Cell Cultures and Tissue Samples-RSF were isolated from freshly dispersed tissue of patients with rheumatoid arthritis as described by Unemori et al. (19) . Culture medium was replaced every 2-3 days. Subcultures were obtained by trypsin/EDTA treatment at a split ratio of 1:3. The cells were used after two or six passages. Conditioned media were obtained by incubating the cells in 10-cm 2 dishes for 24 h with 1.5 ml of medium 199 supplemented with 0.1% human serum albumin, 50 g/ml streptomycin, and 50 IU/ml penicillin, to which the appropriate concentration of test compound was added (10 ng/ml TNF-␣ or 10 nM PMA). The conditioned media were centrifuged for 4 min at 13,000 ϫ g in a microcentrifuge to remove cells and cellular debris, and samples were frozen at Ϫ20°C until used. Human umbilical vein endothelial cells (HUVEC) were isolated and cultured as described previously (20, 21) . Gingival fibroblasts were established from healthy oral mucosa taken from the biopsies of gingiva during operations on maxillary canines and cultured as described earlier (22) . Human periodontal ligament fibroblasts were obtained and cultured by a technique described earlier by Oikarinen and Seppä (23) . Human oral mucosal keratinocytes were cultured as described in detail by Salo et al. (22) . Human squamous cell carcinoma cells (ATCC number CRL 1628) were cultured as described previously (24) . Bone marrow samples (n ϭ 5) were obtained from patients (ages 4 -13 years) being operated on for orthopedic reasons. PMN were isolated and purified from blood of healthy volunteers (25, 26) . The permission for all of these protocols was approved by the Ethical Committee of the University of Oulu. For collecting the media for Western blot analysis, the cells were washed with phosphate-buffered saline (PBS) and incubated for 24 h with medium 199 without serum.
RNA Analysis-For RNA analysis total cellular RNA was extracted from cultured cells: RSF, squamous cellular carcinoma, gingival fibroblasts, periodontal ligament fibroblasts, HUVEC, and keratinocytes. In addition, RNA was isolated from human bone marrow, alveolar bone, and radicular jaw cyst specimen and from purified PMN immediately frozen in liquid nitrogen after purification. RNA extraction and purification were performed as described (27) . Northern blot analysis was carried out as described previously (28) . For reverse transcription (RT), 0.1-20 g of RNA was reverse transcribed as described previously (21) , using oligo(dT) as a primer. Cycles (denaturation step at 95°C for 30 s, annealing step at 55°C for 30 s, and extension step at 72°C for 30 s) were performed using a thermal reactor. Specific primers for MMP-8 (not recognizing MMP-1 or other MMPs) were designed, based on the published DNA sequence (9): MMP-8 sense primer 5Ј-AAGGCAAC-CAATACTGGG, and MMP-8 antisense primer 5Ј-ATTTTCACGGAG-GACAGG. The size of the expected PCR product was 522 bp (29) . Primers for the constitutively expressed housekeeping gene ␤-actin were as described previously (30) : ␤-actin sense primer, 5Ј-AAGAT-GACCCAGATCATGTTTGAG; antisense primer, 5Ј-AGGAGGAG-CAATGATCTTGATCTT; expected product size 652 bp. PCR analysis was also carried on human genomic DNA (28) . The 522-bp PCR products from human bone marrow, peripheral blood PMN, and human gingival fibroblasts were isolated, subcloned, and sequenced (28) . The probe for MMP-8 was obtained by PCR of mRNA from bone marrow and was characterized by sequencing.
Western Blot Analysis-For Western blot analysis, serum-free cell culture medium (200 l) or purified PMN MMP-8 (5-10 ng) was freezedried and resuspended in 100 l of 10 mM Tris-HCl, pH 7.8, run on 7.5% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose filter paper. Nonspecific binding was eliminated by incubating with PBS supplemented with 5% non-fat dry milk for 90 min at 37°C. The blots were incubated either with rabbit polyclonal antibodies (affinitypurified IgG fractions) against human MMP-8 (13, 31) diluted 1:1,000 or with nonimmune control serum diluted 1:100 for 1 h at 20°C. After washings, the blots were incubated with biotinylated goat anti-rabbit immunoglobulins (1:500) for 1 h at 20°C. After washing, the blots were incubated for 30 min with the avidin-biotin-horseradish peroxidase kit, and the color was developed using diaminobenzidine. MMP-8 Immunofluorometric Assay-MMP-8 levels were determined by a time-resolved immunofluorescence assay. The monoclonal MMP-8-specific antibodies 8708 and 8706 were used as a catching antibody and a tracer antibody, respectively. The tracer antibody was labeled using europium-chelate (32) . The assay buffer contained 20 mM TrisHCl, pH 7.5, 0.5 M NaCl, 5 mM CaCl 2 , 50 M ZnCl 2 , 0.5% bovine serum albumin, 0.05% sodium azide, and 20 mg/liter DTPA. Samples were diluted in assay buffer and incubated for 1 h, followed by incubation for 1 h with tracer antibody. Enhancement solution was added, and after 5 min fluorescence was measured using a 1234 Delfia Research Fluorometer (Wallac, Turku, Finland). MMP-8 was purified from human neutrophil extracts according to Sorsa et al. (7) . The specificity of the monoclonal antibodies against MMP-8 corresponded to that of polyclonal MMP-8 (data not shown).
Glycosylation Analysis-Endoglycosidase digestions of MMP-8 purified from PMN and from culture media of PMA-stimulated RSF and HUVEC were carried out using a modification of the method described by Mallya et al. (33) . Briefly, endoglycosidase F digestion was carried out in 20 mM potassium phosphate, pH 7.2, containing 50 mM EDTA, 0.1% SDS, 1% 2-mercaptoethanol, and 1% CHAPS at 37°C; the reaction with N-glycosidase F was done in 100 mM phosphate buffer, pH 7.2, containing 25 mM EDTA, 0.1% SDS, 1.0% 2-mercaptoethanol, and 1% CHAPS. In the deglycosylation reaction of both 0.05-0.2 mg/ml purified PMN MMP-8 or culture media of RSF and HUVEC, 0.05 unit of endoglycosidase F or 0.2 unit of N-glycosidase F was used. Before the addition of endoglycosidase, samples were denaturated by heating at 100°C for 5 min in the presence of 0.1% SDS. The reactions were terminated after overnight incubation by addition of SDS-polyacrylamide gel electrophoresis sample buffer and boiling for 5 min.
Immunohistochemical Staining-Antiserum to neutrophil type MMP-8 collagenase used for immunohistochemical staining was the same as that used for immunoblotting (13, 31 ). 6-m-thick cryostat sections of synovial membrane from six rheumatoid arthritis patients were mounted on gelatin-coated slides and fixed in acetone at 4°C for 5 min and washed in 0.1 M PBS, pH 7.4, at 22°C before the inhibition of endogenous peroxidase by immersing the sections in 0.3% hydrogen peroxide in methanol for 20 min. The slides were placed in a humid chamber, and the sections were incubated sequentially with 1) rabbit anti-human antiserum against MMP-8, diluted 1:100 -1:400 in PBS and 0.1% w/v BSA for 1 h; 2) biotinylated horse anti-rabbit IgG, diluted 1:100 in PBS with 0.1% w/v bovine serum albumin for 30 min; and 3) avidin-biotin-horseradish peroxidase complex, diluted 1:200 in PBS for 30 min. Finally, the sections were incubated for 5 min in a chromogen solution of 3,3Ј-diaminobenzidine (50 mg/150 ml of PBS) and hydrogen peroxide (final concentration 0.03%). All incubations were performed at 22°C, and slides were washed twice in PBS between each step. All slides containing consecutive sections were processed further with and without counterstaining with hematoxylin before dehydration in ethanol, clearing in xylene, and mounting. Omission of primary antiserum and use of normal rabbit serum (diluted 1:100 -1:400) were included as controls.
Measurement of Collagenase Activity against Soluble Type I and II Collagens-RSF were incubated for 24 h with 10 ng/ml TNF-␣. Media were collected, treated with 1 mM APMA, and incubated for 12 h at 22°C with 1.5 M native soluble type I or II collagen in 50 mM Tris-HCl, 0.15 M NaCl, 1 mM CaCl 2 , pH 7.8, in the presence or absence of 50 M doxycycline. The collagen degradation products were separated by 8% SDS-polyacrylamide gel electrophoresis. The amount of type I or type II collagen cleaved by collagenases (MMP-1 and/or MMP-8) was analyzed by scanning the bands on gel at 595 nm using an ISCO gel scanner. Collagenase activity is expressed as a percentage of collagen degraded (5, 34).
RESULTS

MMP-8 Expression in Several Cell
Types and Tissues-Using a sensitive RT-PCR method we analyzed whether the expression of MMP-8 mRNA could be detected in tissues other than the bone marrow. Indeed, a 522-bp MMP-8 transcript amplified from total RNA was detected in peripheral blood PMN; fibroblastic cell lines derived from mucosa (gingival fibroblasts), periodontal ligament, or rheumatoid synovia (RSF); cultured squamous cell carcinoma cells of the tongue (squamous cellular carcinoma); and HUVEC, whereas no amplified transcript was observed in cultured human oral keratinocytes (Figs. 1-3) . The specificity of PCR amplification of the RSF mRNA was verified by Southern blot analysis using a specific MMP-8 cDNA probe (Figs. 2 and 3) . Using the same MMP-8 primers as those used for MMP-8 RT-PCR, PCR amplification was carried out on human genomic DNA, resulting in a 1,400-bp product, indicating that the area of genomic MMP-8 DNA corresponding to the 522-bp mRNA RT-PCR product contains noncoding introns of the MMP-8 gene (not shown). In addition, the 522-bp PCR products were isolated, subcloned, and sequenced, which revealed 100% homology with the published human MMP-8 sequence (15) .
Regulation of MMP-8 Expression in RSF and HUVEC by TNF-␣ and PMA-Regulation of MMP-8 expression in RSF and HUVEC was studied by treating the cells with 10 ng/ml TNF-␣ or 10 nM PMA. After isolation RNA was analyzed by using semiquantitative RT-PCR followed by Southern analysis, or by Northern analysis. RT-PCR of RSF RNA showed a 522-bp fragment, and the amount of the amplified product was increased 5-fold after the treatment of TNF-␣, and 3-4-fold after PMA treatment (Fig. 2B) . For HUVEC also nonspecific bands were observed after RT-PCR (Fig. 3A) . However, Southern blotting revealed results similar to those obtained for RSF (Fig.  3B) . The amount of amplified ␤-actin DNA was constant in control, TNF-␣-, or PMA-treated cells (Fig. 3C) . The presence of MMP-8 mRNA was also confirmed by Northern blot analysis (Fig. 2, C and D) . The 3.3-kb MMP-8 mRNA was observed in TNF-␣-and PMA-treated cells, whereas using this method no MMP-8 mRNA could be detected in untreated cells (Fig. 2C) . Thus, both in fibroblasts and in endothelial cells MMP-8 is expressed and regulated by inflammatory mediators or phorbol ester.
Expression of MMP-8 Protein in RSF and HUVEC-To analyze MMP-8 protein expression and secretion, Western blot analysis was carried out on culture supernatants of RSF. A 50-kDa immunoreactive band was observed by using MMP-8-specific polyclonal antibodies (Fig. 4) . The MMP-8-specific antibody used in this study did not recognize the related fibroblast collagenase (MMP-1) or other MMPs (MMP-2, MMP-3, MMP-9) because excessive amounts of these proteins showed no cross-reactivity in Western blotting (Fig. 4A) . At the protein level the induction of MMP-8 was seen also, both in TNF-␣-and PMA-treated cells (Fig. 4B, lanes 3 and 4) . Only very weak immunoreactivity was found in the culture media of untreated RSF (Fig. 4B, lane 2) . MMP-8 expression levels in RSF were measured by enzyme-linked immunosorbent assay. In conditioned media of RSF (passage 0 and passage 2 from two different isolations) an MMP-8 production of 6.7 Ϯ 4.0 ng/ml/24 h was determined.
We assume that the 50-kDa band most likely represents the Amplified transcripts, such as those described in panel A, were transferred to nylon filters and hybridized with 32 P-labeled MMP-8 DNA probe. Panel C, MMP-8 RNA analysis using Northern blotting. RNA samples (7.5 g) were subjected to Northern blotting and hybridized using a (Fig. 5A) , whereas the treatment of media from PMA-treated HUVEC or RSF did not show any clear changes in the molecular mass of secreted 50 kDa MMP-8 (Fig. 5B) .
In Vivo Expression of MMP-8 in Rheumatoid Synovial
Tissue-Detection of MMP-8 by immunohistochemistry showed MMP-8 expression in mononuclear fibroblast-like cells in the human rheumatoid synovial membrane (Fig. 6A) , whereas no immunostaining was observed using nonimmune sera (Fig.  6B) . Similar in vivo results were found in tissues from chronically inflamed gingiva and oral mucosa (data not shown).
Inhibition of RSF MMP-8 Activity by Doxycycline-Collagenase activity in culture media of RSF, treated with TNF-␣, degraded efficiently both native type I and II collagens into the characteristic ␣A(3/4) cleavage products (Fig. 7, lanes 2 and 5) . Previous studies (34) have shown that doxycycline is a strong inhibitor of MMP-8 activity compared with MMP-1 activity (IC 50 of 30 and 300 M, respectively). Preincubation of culture media from RSF with 50 M doxycycline completely prevented the specific degradation of type II collagen (Fig. 7, lane 6 ) but had no effect on the degradation of type I collagen (Fig. 7, lane 3) . Thus, RSF do produce MMP-8 which, as shown before (9), prefers type II collagen to type I collagen as a substrate, and its catalytical activity is specifically inhibited by doxycycline. Similar results were found in culture media of endothelial cells (not shown). HUVEC-We investigated further whether doxycycline affects the level of MMP-8 expression. Northern blot analysis of RSF, treated with TNF-␣ or PMA in the presence of doxycycline, showed a clear reduction in the amount of 3.3-kb MMP-8 mRNA (Fig. 8, A and B) . A similar result was obtained using RT-PCR (Fig. 8, C and D) . In addition, MMP-8 protein was reduced in cells treated with TNF-␣ or PMA in the presence of doxycycline (Fig. 8, E and F) . Obviously, doxycycline not only inhibits the collagenolytic activity of MMP-8 but also affects the induced expression of the 50-kDa MMP-8 protein in synovial fibroblasts.
Effects of Doxycycline on MMP-8 Expression in RSF and
DISCUSSION
Human neutrophil collagenase (MMP-8) is regarded as a PMN-specific matrix metalloproteinase that is stored in granules and released upon cell activation. This study shows that in addition to peripheral PMN, MMP-8 is expressed in RSF and human endothelial cells. This was demonstrated by RT-PCR, Northern blotting (showing the MMP-8-specific mRNA size of 3.3 kb), Western blotting, immunohistochemistry, substrate specificity, and specific inhibition of enzyme activity by doxycycline. Upon MMP-8 synthesis, which is regulated in these cells by the inflammatory mediator TNF-␣, the protein is secreted. MMP-8, interstitial collagenase (MMP-1), and collagenase-3 (MMP-13) are the main proteases that can degrade different types of native collagen. MMP-8 has the highest activity toward cartilage collagen type II. In pathophysiological conditions MMP-8 is regarded as playing a central role at sites of matrix degradation; MMP-8 activity was shown in chronic bronchiectasis (35) , cystic fibrosis, in which the level of activity correlated to the disease state (36) , and rheumatoid arthritis (37) . In addition, MMP-8 is thought to be the only collagenase that acts in cartilage aggrecan degradation (38) . Because its synthesis and storage were considered to be restricted to maturating PMN only, MMP-8 activity at sites of tissue destruction was thought to be mediated by the degranulation of PMN (4, 9, 15) . In contrast to previous studies, we show that the regulation of tissue destruction by MMP-8 is most likely more complicated, and MMP-8 expression comprises various cell types and tissues. On the basis of our results we hypothesize that as with other members of the MMP family, the expression of MMP-8 is regulated by inflammatory mediators such as TNF-␣ and interleukin-1 (19, 21) . Recently, Cole and Kuettner (16) reported the expression of MMP-8 mRNA in circulating PMN. In addition, the demonstration of MMP-8 expression in cartilage, in particular in human articular chondrocytes (16 -18) , is of interest and supports our conclusion that MMP-8 transcripts are also present in various types of mesenchymal cells, especially in those collected from chronically inflamed tissues, such as found in rheumatoid arthritis and inflamed gingiva.
The molecular mass of the MMP-8 protein published varies between 85 and 50 kDa, even though forms as small as 20 kDa have been reported by different research groups (7, 12, 39) . The variance probably reflects a different degree of MMP-8 glycosylation and whether the enzyme is found in a latent or an active form. In addition, degraded forms of MMP-8 protein may have been detected as well. In this study we observed that MMP-8 was present as a 75-85 kDa protein in PMN. However, only the 50-kDa form was seen in RSF as well as in HUVEC. After deglycosylation of the 75-kDa MMP-8 purified from PMN, the enzyme appeared as four different size bands, one of which corresponded to the size of MMP-8 expressed by RSF. Deglycosylation of the 50-kDa MMP-8 from RSF or HUVEC showed that this secreted form of MMP-8 is glycosylated significantly less or hardly at all compared with the PMN MMP-8. Therefore, it can be speculated that subgranularly stored MMP-8 in PMN requires carbohydrate moieties, whereas a low or nonglycosylated form is secreted as a latent enzyme, similar to other secreted MMPs.
Doxycycline, a commonly used broad spectrum antibiotic, inhibits MMP-8 activity at low concentrations but not that of MMP-1 (7, 34, 40) . We confirmed these studies showing that the activity of MMP-8, including the nonglycosylated form secreted by RSF and HUVEC, is inhibited efficiently by 50 M doxycycline. Lauhio et al. (40) have shown that long term doxycycline treatment reduced MMP-8 serum levels in reactive arthritis. The mechanism of this reduction is not known. Therefore, we investigated whether doxycycline may affect MMP-8 synthesis. It was observed that after preincubation with 50 M doxycycline in RSF as well as in HUVEC both MMP-8 mRNA and MMP-8 protein expression was down-regulated, indicating that doxycycline inhibits not only MMP-8 activity but also its synthesis.
With respect to the demonstrated anti-arthritic effects of doxycycline (7, 40, 41) and the related chemically modified tetracyclines (42), our present findings are relevant to the recent observation that MMP-8 uniquely exerts "aggreganase activity" (17, 38) . On the basis of the present and previously published in vivo and in vitro results (7, 40, 41) , this inhibition of degrading activity can be realized by doxycycline concentration attainable in vivo (41) , at the level of both proteolytic activity and synthesis. Because it has become evident that human cytokine-stimulated synovial fibroblasts, endothelial cells (this study), and joint chondrocytes (18) produce mesenchymal-type MMP-8 species, doxycycline and probably also tetracyclines non-antimicrobial chemically modified (CMTs) may be potential drugs for counteracting the degradation of both articular collagen and proteoglycans in vivo.
In summary, previously MMP-8 was considered to be uniquely expressed by neutrophils during their development in bone marrow, and thus MMP-8 was referred to as neutrophil collagenase. The results of the present study show that in addition to peripheral blood PMNs several non-PMN lineage cells, such as fibroblasts and endothelial cells, are able to express MMP-8 mRNA and protein both in vivo and in vitro. Therefore, we suggest that in future human neutrophil collagenase (MMP-8) should be referred to as collagenase-2 (Cl-2).
